Hem › Akut lymfoblastisk leukemi › Massachusetts
Kliniska studier för Akut lymfoblastisk leukemi i Massachusetts
15 studier för Akut lymfoblastisk leukemi söker deltagare vid platser i Massachusetts.
Städer i Massachusetts
Officiell studietext (engelska)
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- Dana-Farber/Boston Children s Hospital, Boston
Rekryterar
Ålder 1 till 25 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05621291Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- Dana-Farber Cancer Institute, Boston
RekryterarFas 1/2
Ålder 16 till 75 · Alla kön · Uppdaterad 10 sep. 2026 · NCT03104491The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Dana-Farber Cancer Institute, Boston
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241ALL Backbone in AYAs
- Dana Farber Cancer Institute, Boston
RekryterarFas 2
Ålder 18 till 51 · Alla kön · Uppdaterad 17 aug. 2026 · NCT07227584Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Children's Hospital Corporation d/b/a Boston Children's Hospital, Boston
RekryterarObservationsstudie
1 Day – 17 Years · Alla kön · Uppdaterad 14 aug. 2026 · NCT06274788A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Brigham and Women's Hospital, Boston
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 75 · Alla kön · Uppdaterad 28 juli 2026 · NCT07020533A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Tufts Medical Center, Boston
- Beth Israel Deaconess, Boston
- Dana Farber Cancer Institute, Boston
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Dana-Farber Cancer Institute, Boston
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 18 maj 2026 · NCT01790152Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- Dana Farber Cancer Institute, Boston
RekryterarFas 1
Ålder 13 och äldre · Alla kön · Uppdaterad 5 maj 2026 · NCT04771572A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Massachusetts General Hospital, Boston
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 24 mars 2026 · NCT04988555A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Dana-Farber Cancer Institute, Boston
RekryterarFas 2
Ålder 18 till 66 · Alla kön · Uppdaterad 17 mars 2026 · NCT06859424Venetoclax Basket Trial for High Risk Hematologic Malignancies
- Dana-Farber Cancer Institute, Boston
RekryterarFas 1
Ålder 1 till 40 · Alla kön · Uppdaterad 12 mars 2026 · NCT05292664CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- DFCI/BWH Brigham and Women's Hospital, Boston
RekryterarFas 2Friska volontärer välkomna
Ålder 18 till 75 · Alla kön · Uppdaterad 10 mars 2026 · NCT06059391Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Dana-Farber Cancer Institute, Boston
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 15 apr. 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Dana-Farber Cancer Institute, Boston
RekryterarFas 1
Ålder 1 till 21 · Alla kön · Uppdaterad 6 dec. 2024 · NCT05476770Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.